- Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. Ilson, D.H., Bains, M., Kelsen, D.P., O'Reilly, E., Karpeh, M., Coit, D., Rusch, V., Gonen, M., Wilson, K., Minsky, B.D. J. Clin. Oncol. (2003)